Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028)
Awarded
The competition has ended and a winner has been selected.
Farmasøytisk engroshandel
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2024-2026. The procurement contains two options to extend the contract for the periods 2026-2027 and 2027-2028. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Result
- Winner
- GlaxoSmithKline Oy
- Number of bids
- 2
- Contract value
- €8,112,000
About the bid
- Contact name
- Tuija Orre
- Contact phone
- +358 295246000
- Contact email
- tuija.orre@thl.fi
- Address
- P.O. BOX 33, 00023 Helsinki
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years 2024-2026. The procurement contains two options to extend the contract for the periods 2026-2027 and 2027-2028. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.Main features of the procedureAn open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive bidding, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
Price
Description
Quality
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Ministry of Social Affairs and Health
- Title
- Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028)
- Type
- Main code
- Supplemental codes
- Location
- Helsinki-Uusimaa
- Duration
- 2 years